BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27708215)

  • 1. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
    Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
    Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
    Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
    Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
    Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
    Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J; Zhang Y; Mu J; He X; Shao B; Zhou D; Peng W; Tang J; Jiang Y; Ren G; Xiang T
    Clin Epigenetics; 2018 Aug; 10(1):103. PubMed ID: 30075814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
    Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
    Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
    Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
    Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.
    Jia Y; Yang Y; Brock MV; Zhan Q; Herman JG; Guo M
    J Pathol; 2013 Jun; 230(2):194-204. PubMed ID: 22806826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.
    Marusa Borgonio-Cuadra V; Miranda-Duarte A; Rojas-Toledo X; Garcia-Hernandez N; Alfredo Sierra-Ramirez J; Cardenas-Garcia M; Elena Hernandez-Caballero M
    J BUON; 2018; 23(2):361-365. PubMed ID: 29745077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells.
    Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q
    J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
    Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T
    Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
    Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
    Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.
    Gao S; Yang Z; Zheng ZY; Yao J; Zhang F; Wu LM; Xie HY; Zhou L; Zheng SS
    World J Surg Oncol; 2013 Mar; 11():57. PubMed ID: 23496880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.